Moreover, it was observed that agonist of PPAR-α receptor (GW7647) which decreased the expression of sAPPβ and the activity of BACE-1 and Aβ1-42 level in cell model of AD had no effect on the level of APP and Preseniline-1 (PS1). This evidence concerns the gene PSEN1 and Alzheimer disease.